Understanding these TDP-43 CTFs and their role in the pathophysiology of ALS and FTDL is essential not only to understand the etiology of the diseases but also to target TDP-43 in its various forms (total, fragments) in order to avoid the formation of aggregates or promote their clearance. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.